Clinical and Experimental Reproductive Medicine

Ovarian volume is more closely related to the different manifestations of polycystic ovary syndrome than follicle number per ovary: Shazia Afrine, Jasmine Ara Haque, Md Shahed Morshed, Hurjahan Banu, Ahmed Hossain, Muhammad Abul Hasanat; Clin Exp Reprod Med. 2023;50(3):200-205. Published online June 13, 2023; DOI: https://doi.org/10.5653/cerm.2023.05897; Full text PubReader ePub Crossref - TDM PDF

Relationship between hematologic parameters related to systemic inflammation and insulin resistance-associated metabolic parameters in women with polycystic ovary syndrome: Minkyung Cho, Suji Kim, Sungwook Chun; Clin Exp Reprod Med. 2023;50(3):206-212. Published online May 19, 2023; DOI: https://doi.org/10.5653/cerm.2023.05932; Full text PubReader ePub Crossref - TDM PDF

Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome: Jeong Eun Lee, Yubin Park, Jisoo Lee, Sungwook Chun; Clin Exp Reprod Med. 2023;50(2):117-122. Published online May 11, 2023; DOI: https://doi.org/10.5653/cerm.2023.05855; Full text PubReader ePub Crossref - TDM PDF

Therapeutic effect of Ferula assa-foetida oleo-gum resin in rats with letrozole-induced polycystic ovary syndrome: Amir Shieh, Seyyed Majid Bagheri, Maryam Yadegari, Davoud Javidmehr, Zeinab Farhadi; Clin Exp Reprod Med. 2022;49(4):239-247. Published online November 24, 2022; DOI: https://doi.org/10.5653/cerm.2022.05449
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome: Vu Ngoc Anh Ho, Toan Duong Pham, Nam Thanh Nguyen, Hieu Le Trung Hoang, Tuong Manh Ho, Lan Ngoc Vuong; Clin Exp Reprod Med. 2022;49(2):127-134. Published online May 27, 2022; DOI: https://doi.org/10.5653/cerm.2022.05204; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Association between the serum estrone-to-estradiol ratio and parameters related to glucose metabolism and insulin resistance in women with polycystic ovary syndrome: Nayoung Kim, Sungwook Chun; Clin Exp Reprod Med. 2021;48(4):374-379. Published online December 1, 2021; DOI: https://doi.org/10.5653/cerm.2021.04553
Cited By 3; Full text PubReader ePub Crossref - TDM PDF

Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome: Bulut Varlı, Yavuz Emre Şükür, Batuhan Özmen, Berrin İmge Ergüder, Murat Sönmezer, Bülent Berker, Cem Atabekoğlu, Ruşen Aytaç; Clin Exp Reprod Med. 2021;48(4):368-373. Published online November 30, 2021; DOI: https://doi.org/10.5653/cerm.2021.04420; Full text PubReader ePub Crossref - TDM PDF

Update on polycystic ovary syndrome: Jin Ju Kim; Clin Exp Reprod Med. 2021;48(3):194-197. Published online August 24, 2021; DOI: https://doi.org/10.5653/cerm.2020.04329
Cited By 4; Full text PubReader ePub Crossref - TDM PDF

The effect of genistein on insulin resistance, inflammatory factors, lipid profile, and histopathologic indices in rats with polycystic ovary syndrome: Sasan Amanat, Fatemeh Ashkar, Mohammad Hassan Eftekhari, Nader Tanideh, Saeid Doaei, Maryam Gholamalizadeh, Farhad Koohpeyma, Maral Mokhtari; Clin Exp Reprod Med. 2021;48(3):236-244. Published online August 20, 2021; DOI: https://doi.org/10.5653/cerm.2020.04231
Cited By 6; Full text PubReader ePub Crossref - TDM PDF

Alteration of TGFB1, GDF9, and BMPR2 gene expression in preantral follicles of an estradiol valerate-induced polycystic ovary mouse model can lead to anovulation, polycystic morphology, obesity, and absence of hyperandrogenism: Reza Asghari, Vahid Shokri-Asl, Hanieh Rezaei, Mahmood Tavallaie, Mostafa Khafaei, Amir Abdolmaleki, Abbas Majdi Seghinsara; Clin Exp Reprod Med. 2021;48(3):245-254. Published online August 6, 2021; DOI: https://doi.org/10.5653/cerm.2020.04112
Cited By 5; Full text PubReader ePub Crossref - TDM PDF

Predictive capability of fasting-state glucose and insulin measurements for abnormal glucose tolerance in women with polycystic ovary syndrome: Sungwook Chun; Clin Exp Reprod Med. 2021;48(2):156-162. Published online June 1, 2021; DOI: https://doi.org/10.5653/cerm.2020.04308
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

The effect of insemination methods on in vitro maturation outcomes: Pallop Pongsuthirak; Clin Exp Reprod Med. 2020;47(2):130-134. Published online May 14, 2020; DOI: https://doi.org/10.5653/cerm.2019.03300
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Clinical application of serum anti-Müllerian hormone in women: So Ra Oh, Sun Yi Choe, Yeon Jean Cho; Clin Exp Reprod Med. 2019;46(2):50-59. Published online June 1, 2019; DOI: https://doi.org/10.5653/cerm.2019.46.2.50
Cited By 35; Full text PubReader ePub Crossref - TDM PDF

Early gonadotropin-releasing hormone antagonist protocol in women with polycystic ovary syndrome: A preliminary randomized trial: Jae Jun Shin, Kyung Eui Park, Young Min Choi, Hye-Ok Kim, Dong-Hee Choi, Woo Sik Lee, Jung-Hyun Cho; Clin Exp Reprod Med. 2018;45(3):135-142. Published online September 3, 2018; DOI: https://doi.org/10.5653/cerm.2018.45.3.135
Cited By 5; Full text PubReader Crossref - TDM PDF

Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome: Sibel Sak, Hacer Uyanikoglu, Adnan Incebiyik, Hatice Incebiyik, Nese Gul Hilali, Tevfik Sabuncu, Erdal Sak; Clin Exp Reprod Med. 2018;45(3):116-121. Published online September 3, 2018; DOI: https://doi.org/10.5653/cerm.2018.45.3.116
Cited By 12; Full text PubReader Crossref - TDM PDF

Search